BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36359470)

  • 21. Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients.
    Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Petrica L
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine proteomics identifies biomarkers for diabetic kidney disease at different stages.
    Fan G; Gong T; Lin Y; Wang J; Sun L; Wei H; Yang X; Liu Z; Li X; Zhao L; Song L; He J; Liu H; Li X; Liu L; Li A; Lu Q; Zou D; Wen J; Xia Y; Wu L; Huang H; Zhang Y; Xie W; Huang J; Luo L; Wu L; He L; Liang Q; Chen Q; Chen G; Bai M; Qin J; Ni X; Tang X; Wang Y
    Clin Proteomics; 2021 Dec; 18(1):32. PubMed ID: 34963468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).
    van der Kloet FM; Tempels FW; Ismail N; van der Heijden R; Kasper PT; Rojas-Cherto M; van Doorn R; Spijksma G; Koek M; van der Greef J; Mäkinen VP; Forsblom C; Holthöfer H; Groop PH; Reijmers TH; Hankemeier T
    Metabolomics; 2012 Feb; 8(1):109-119. PubMed ID: 22279428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Metabolomics Benefits Discrimination Kidney Disease Development in Type 2 Diabetes Patients.
    Peng X; Wang X; Shao X; Wang Y; Feng S; Wang C; Ye C; Chen J; Jiang H
    Front Med (Lausanne); 2022; 9():819311. PubMed ID: 35615098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of microbial metabolites in diabetic kidney disease.
    Zhu T; Hu BY; Zhang YQ; Zhang ZY; Cai KW; Lei L; Hu B; Wang XH; Tang C; Lu YP; Zheng ZH
    Heliyon; 2023 Jul; 9(7):e17844. PubMed ID: 37539130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
    Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
    Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Untargeted Metabolomic Plasma Profiling of Emirati Dialysis Patients with Diabetes versus Non-Diabetic: A Pilot Study.
    Banimfreg BH; Alshraideh H; Shamayleh A; Guella A; Semreen MH; Al Bataineh MT; Soares NC
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
    Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
    Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
    [No Abstract]   [Full Text] [Related]  

  • 31. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X; Dong Y; Liu M; Li Y; Zhang Y
    Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients With Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease Exhibit Lower Computed Tomography-measured Skeletal Muscle Attenuation Values: A Propensity Score-matched Study.
    Fan J; Zuo L; Li F; Wang B; An Y; Yu D
    J Ren Nutr; 2024 May; ():. PubMed ID: 38777307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.
    Hasegawa S; Inagi R
    Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
    Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
    [No Abstract]   [Full Text] [Related]  

  • 37. Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease.
    Feng X; Huang J; Peng Y; Xu Y
    BMC Endocr Disord; 2021 Jan; 21(1):1. PubMed ID: 33407357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease.
    Fan X; Xu M; Chen X; Ren Q; Fan Y; Wang R; Chen J; Cui L; Wang Z; Sun X; Guo N
    Front Endocrinol (Lausanne); 2022; 13():1001391. PubMed ID: 36277688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
    Zhao B; Zhang M; Xie J; Jiang T; Li J; Yang Z
    Int Immunopharmacol; 2022 Aug; 109():108916. PubMed ID: 35679662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione Peroxidase 4 Is a Predictor of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Wang YH; Chang DY; Zhao MH; Chen M
    Oxid Med Cell Longev; 2022; 2022():2948248. PubMed ID: 36275902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.